Together, these data highlight the accumulation of PD1+ CD57+ CD8+ TEMRA cells during the prodromal phase of AD, and link lower PD1 expression on these cells to increased CSF biomarkers indicative of AD pathology. This evidence concerns the gene B3GAT1 and Alzheimer disease.